Lab News
6 trends to watch at AACC 2020
December 14, 2020 -- Although this year's meeting of the American Association for Clinical Chemistry (AACC) is virtual, it is probably more important than ever. Bruce Carlson of market research firm Kalorama Information will be watching six trends at AACC 2020.
Discuss
December 14, 2020 -- Although this year's meeting of the American Association for Clinical Chemistry (AACC) is virtual, it is probably more important than ever. Bruce Carlson of market research firm Kalorama Information will be watching six trends at AACC 2020.
Discuss Bayer, Tempus join forces on cancer testing
December 11, 2020 -- Bayer and Tempus are partnering to provide broader access to genomic testing and tailored treatment approaches for the oncology community. They plan to help facilitate patient identification for precision oncology by providing testing via the Tempus xT broad-panel genomic sequencing assay.
December 11, 2020 -- Bayer and Tempus are partnering to provide broader access to genomic testing and tailored treatment approaches for the oncology community. They plan to help facilitate patient identification for precision oncology by providing testing via the Tempus xT broad-panel genomic sequencing assay.
AACC sets 2021 meeting for Anaheim in September
December 10, 2020 -- The American Association for Clinical Chemistry (AACC) announced on December 10 that the 2021 edition of its annual meeting will take place September 19-23 in Anaheim, CA. The AACC said it hopes the later date will make it possible for the meeting to be held in person.
Discuss
December 10, 2020 -- The American Association for Clinical Chemistry (AACC) announced on December 10 that the 2021 edition of its annual meeting will take place September 19-23 in Anaheim, CA. The AACC said it hopes the later date will make it possible for the meeting to be held in person.
Discuss New assay offers rapid SARS-CoV-2 antibody testing
December 10, 2020 -- Researchers have developed a new blood assay that uses optical biosensor technology to test for SARS-CoV-2 antibodies in under 20 minutes, according to a study published on December 10 in Scientific Reports.
December 10, 2020 -- Researchers have developed a new blood assay that uses optical biosensor technology to test for SARS-CoV-2 antibodies in under 20 minutes, according to a study published on December 10 in Scientific Reports.
Researchers develop new COVID-19 diagnosis technology
December 10, 2020 -- South Korean researchers have developed a new technology for point-of-care diagnosis of COVID-19, according to a study published December 3 in Nature Biomedical Engineering.
December 10, 2020 -- South Korean researchers have developed a new technology for point-of-care diagnosis of COVID-19, according to a study published December 3 in Nature Biomedical Engineering.
LabCorp gets EUA for Pixel at-home COVID-19 kits
December 9, 2020 -- LabCorp has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for Pixel by LabCorp, a kit that will enable users to collect COVID-19 test samples at home. The test will be made available over the counter, without a prescription.
December 9, 2020 -- LabCorp has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for Pixel by LabCorp, a kit that will enable users to collect COVID-19 test samples at home. The test will be made available over the counter, without a prescription.
FDA clears Mesa Biotech's point-of-care Strep A test
December 9, 2020 -- The U.S Food and Drug Administration (FDA) granted 510(k) clearance and a CLIA waiver to Mesa Biotech for its Accula Strep A molecular point-of-care test.
December 9, 2020 -- The U.S Food and Drug Administration (FDA) granted 510(k) clearance and a CLIA waiver to Mesa Biotech for its Accula Strep A molecular point-of-care test.
Breast cancer survival linked to CTCs found in blood
December 9, 2020 -- The overall survival of patients with metastatic breast cancer was associated with early circulating tumor cells (CTCs) that are shed in the bloodstream, according to an analysis presented at the 2020 San Antonio Breast Cancer Symposium held December 8-11.
December 9, 2020 -- The overall survival of patients with metastatic breast cancer was associated with early circulating tumor cells (CTCs) that are shed in the bloodstream, according to an analysis presented at the 2020 San Antonio Breast Cancer Symposium held December 8-11.
Bluejay teams up with Toray on COVID-19 point-of-care test
December 8, 2020 -- Bluejay Diagnostics and Toray Industries are collaborating to develop a point-of-care diagnostic test for assessing disease progression in COVID-19 patients. The test is designed as a triage aid for predicting patients at risk for intubation.
December 8, 2020 -- Bluejay Diagnostics and Toray Industries are collaborating to develop a point-of-care diagnostic test for assessing disease progression in COVID-19 patients. The test is designed as a triage aid for predicting patients at risk for intubation.
Paige lands CE Marks for breast, prostate cancer software
December 8, 2020 -- Pathology artificial intelligence software developer Paige has received the CE Mark for two software applications, its breast cancer detection software and its prostate grading and quantification software.
December 8, 2020 -- Pathology artificial intelligence software developer Paige has received the CE Mark for two software applications, its breast cancer detection software and its prostate grading and quantification software.
Webinars/Videos
Case Study™
Conferences
American Association for Clinical Chemistry (AACC) Annual Scientific Meeting
December 13-17
Online
December 13-17
Online
Society for Laboratory Automation and Screening (SLAS) 2021
January 23-27, 2021
Online
January 23-27, 2021
Online
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
January 28-29, 2021
London, Greater London United Kingdom
A Practical Approach to Surgical Pathology
April 23-25, 2021
Las Vegas, Nevada United States
April 23-25, 2021
Las Vegas, Nevada United States
International Molecular Pathological Epidemiology (MPE) Meeting
May 24-25, 2021
Boston, Massachusetts United States
May 24-25, 2021
Boston, Massachusetts United States
Connect
Latest Tweets